- China to lift price controls on most drugs starting June 1 Updated: May-05-15 6:25 am
BEIJING - Chinese regulators will lift price controls on most pharmaceutical drugs starting June 1 in hopes that the market-driven pricing system will keep medical costs in check, the National Development and Reform Commission announced Tuesday.
- CVS Health tops Street forecasts, as 1Q earnings climb 8 pct Updated: May-01-15 12:16 pm
Pricey specialty drugs are helping CVS Health thrive after kicking tobacco sales, with revenue from the treatments pushing first-quarter earnings well above Wall Street expectations for the drugstore chain and pharmacy benefits manager.
- Mylan raises offer for Perrigo to $34.1B, or $232 per share Updated: Apr-29-15 1:40 pm
NEW YORK - Generic drugmaker Mylan raised its offer for over-the-counter medicines maker Perrigo Wednesday, but the Irish company again rejected Mylan's overture.
- Genetic testing moves into world of employee health Updated: Apr-28-15 8:41 pm
Your employer may one day help determine if your genes are why your jeans have become too snug.
- Pfizer, despite dollar and generics fight, still impresses Updated: Apr-28-15 1:53 pm
Cost-cutting and sales of new drugs helped Pfizer overcome a strong dollar and patent expirations to beat Wall Street projections for the first quarter, though it cut its outlook for the year, citing the unfavorable currency exchange rates.
- Insurance department explores health care payment reform Updated: Apr-24-15 2:07 pm
CONCORD, New Hampshire - Health care spending is high and rising in New Hampshire, and the state should consider holding both providers and insurers accountable for improving quality and containing costs, consultants hired by the insurance department said Friday.
- Feds: Beckley VA subbed mental health drugs for cheaper ones Updated: Apr-22-15 5:02 pm
CHARLESTON, West Virginia - An investigation has found the Beckley VA Medical Center improperly substituted mental health treatments with older drugs to save money.
- Lawsuit filed over changes to state worker insurance program Updated: Apr-22-15 12:41 pm
BATON ROUGE, Louisiana - A group of state employees and retirees is asking a judge to reverse changes made to their insurance program that cost many workers more out-of-pocket for lessened benefits.
- Amgen tops estimates with 51 percent spike in 1Q profit Updated: Apr-21-15 7:31 pm
TRENTON, New Jersey - Amgen Inc. boosted its first-quarter profit by 51 percent, thanks to surging drug sales and ongoing cost cuts designed to free up cash for an unprecedented burst of new product launches.
- Guam lawmaker proposes debt refinancing to pay for hospital Updated: Apr-20-15 3:54 pm
HAGATNA, Guam - A Guam lawmaker has introduced a bill proposing to refinance the island government's $343 million debt to raise funds for construction of a new Guam Memorial Hospital facility.
- Lawmaker: State should help keep overdose drug affordable Updated: Apr-20-15 3:53 pm
BOSTON - Senate President Stan Rosenberg says Massachusetts should use its purchasing muscle to help ensure that a key drug used to reverse heroin overdoses remains affordable as the state attempts to curb a spike in drug-related deaths.
- New drugs effective at treating hepatitis C, but at a price Updated: Apr-20-15 3:34 am
PROVIDENCE, Rhode Island - Rhode Island Department of Corrections officials say that new drugs are effective at treating hepatitis C. But their steep price has made it difficult to decide when to treat inmates and how to pay for their care.
- US Senate veterans panel to review pricey Denver hospital Updated: Apr-16-15 5:48 pm
DENVER - The U.S. Senate Veterans Affairs Committee will hold a hearing in Colorado next week to scrutinize the bungled VA hospital project and visit the construction site.
- FDA approves new type of heart failure drug from Amgen Updated: Apr-15-15 6:13 pm
TRENTON, New Jersey - Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, are getting a much-needed new option with U.S. approval Wednesday of a novel drug from Amgen Inc.
- IMS: US prescription drug spending jumped 13 pct. in 2014 Updated: Apr-14-15 12:05 am
TRENTON, New Jersey - U.S. spending on prescription drugs soared by 13 percent last year to $374 billion.
- Specialty, generic drug costs drive Medicaid costs up Updated: Apr-11-15 12:38 pm
JEFFERSON CITY, Missouri - The high cost of a drug used to treat Medicaid patients with hepatitis C drew scrutiny from lawmakers earlier this year, but other drugs are also driving up the state's costs and likely will continue to do so for several years, government data reveals.
- Vermont governor alarmed by price spike of heroin antidote Updated: Apr-08-15 11:22 pm
MONTPELIER, Vermont - Gov. Peter Shumlin is urging the maker of an antidote used in drug overdoses to address its rising costs and give Vermont a break on the expense in the interest of saving lives.
- Bristol-Myers could spend $2.2B in deal with Dutch biotech Updated: Apr-06-15 1:50 pm
NEW YORK - Bristol-Myers Squibb, one of the world's largest drugmakers, will team up with a Dutch biotechnology company whose first approved drug could cost more than $1 million.
- Medicare bill helps doctors and kids, but deficit foes cool Updated: Apr-06-15 1:43 pm
WASHINGTON - Republicans say bipartisan legislation reworking how Medicare pays doctors is a milestone toward curbing the huge, growing benefit program.